Inventor · disambiguated record
Peter A. Campochiaro
Also filed as: CAMPOCHIARO PETER · CAMPOCHIARO PETER A · CAMPOCHIARO PETER ANTHONY
26 granted patents·31 pending applications·379 citations·filing 1995–2025
96Inventor score
Top patents by PatentIndex Score
57 records- 0198US8962577B2Controlled release formulations for the delivery of HIF-1 inhibitorsUNIV JOHNS HOPKINS·Filed 2013·Granted Feb 24, 2015·64 cites·45 claims
- 0296US7309483B2Method of treatment using Tie2 ligand2REGENERON PHARMA·Filed 2005·Granted Dec 18, 2007·32 cites·3 claims
- 0393US8258111B2Compositions and methods related to miRNA modulation of neovascularization or angiogenesisSHEN JIKUI·Filed 2009·Granted Sep 4, 2012·48 cites·16 claims
- 0493US5824685AMethod of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonistsUNIV JOHNS HOPKINS MED·Filed 1995·Granted Oct 20, 1998·79 cites·12 claims
- 0591US6479729B1Mouse model for ocular neovascularizationUNIV JOHNS HOPKINS·Filed 2000·Granted Nov 12, 2002·28 cites·16 claims
- 0688US9950072B2Controlled release formulations for the delivery of HIF-1 inhibitorsUNIV JOHNS HOPKINS·Filed 2015·Granted Apr 24, 2018·6 cites·54 claims
- 0786US6075032AMethod of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonistsALLERGAN INC·Filed 1996·Granted Jun 13, 2000·46 cites·20 claims
- 0885US9365852B2Compositions and methods related to miRNA modulation of neovascularization or angiogenesisMIRNA THERAPEUTICS INC·Filed 2015·Granted Jun 14, 2016·2 cites·6 claims
- 0985US7989426B2Selective induction of apoptosis to treat ocular disease by expression of PEDFUNIV JOHNS HOPKINS MED·Filed 2007·Granted Aug 2, 2011·2 cites·10 claims
- 1083US10933144B2Non-linear multiblock copolymer-drug conjugates for the delivery of active agentsUNIV JOHNS HOPKINS·Filed 2018·Granted Mar 2, 2021·2 cites·26 claims
- 1183US6372753B1Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonistsALLERGAN INC·Filed 2000·Granted Apr 16, 2002·12 cites·6 claims
- 1281US2023364247A1Non-linear multiblock copolymer-drug conjugates for the delivery of active agentsUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 1378US10159743B2Non-linear multiblock copolymer-drug conjugates for the delivery of active agentsUNIV JOHNS HOPKINS·Filed 2013·Granted Dec 25, 2018·2 cites·45 claims
- 1478US2024418734A1Biomarkers useful in the treatment of subjects having diseases of the eyeUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 1576US2024293334A1Nonviral gene transfer to the suprachoroidal spaceUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 1675US11660349B2Non-linear multiblock copolymer-drug conjugates for the delivery of active agentsUNIV JOHNS HOPKINS·Filed 2021·Granted May 30, 2023·0 cites·20 claims
- 1772US2024254214A1TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF FabREGENXBIO INC·Filed 2023·Application pending·0 cites
- 1871US12078641B2Biomarkers useful in the treatment of subjects having diseases of the eyeUNIV JOHNS HOPKINS·Filed 2022·Granted Sep 3, 2024·0 cites·6 claims
- 1970US11400070B2Methods of treating retinal diseasesALIMERA SCIENCES INC·Filed 2019·Granted Aug 2, 2022·1 cites·12 claims
- 2070US6071924AMethod of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonistsALLERGAN INC·Filed 1998·Granted Jun 6, 2000·17 cites·17 claims
- 2169US6573271B2Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonistsUNIV JOHNS HOPKINS·Filed 2001·Granted Jun 3, 2003·2 cites·1 claims
- 2267US2010093739A1Method for decreasing capillary permeability in the retinaBRAZZELL ROMULUS KIMBRO·Filed 2009·Application pending·0 cites
- 2366US7268137B2Ocular therapyCAMPOCHIARO PETER A·Filed 2003·Granted Sep 11, 2007·2 cites·13 claims
- 2465US8338384B2Method for treating ocular neovascularizationBRAZZELL ROMULUS KIMBRO·Filed 2010·Granted Dec 25, 2012·1 cites·27 claims
- 2564US11883541B2Nonviral gene transfer to the suprachoroidal spaceUNIV JOHNS HOPKINS·Filed 2018·Granted Jan 30, 2024·0 cites·18 claims
- 2664US9540645B2Compositions and methods related to miRNA modulation of neovascularization or angiogenesisMIRNA THERAPEUTICS INC·Filed 2016·Granted Jan 10, 2017·0 cites·6 claims
- 2764US2025320287A1TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF FabREGENXBIO INC·Filed 2025·Application pending·0 cites
- 2859US6271233B1Method for treating ocular neovascular diseasesNOVARTIS AG·Filed 1999·Granted Aug 7, 2001·21 cites·13 claims
- 2959US2003158112A1Selective induction of apoptosis to treat ocular diseaseUNIV JOHNS HOPKINS MED·Filed 2003·Application pending·0 cites
- 3058US2013065951A1Compositions and methods related to mirna modulation of neovascularization or angiogenesisSHEN JIKUI·Filed 2012·Application pending·0 cites
- 3156US9238057B2Method for treating ocular neovascularizationNOVARTIS AG·Filed 2012·Granted Jan 19, 2016·0 cites·22 claims
- 3256US2006147422A1Selective induction of apoptosis to treat ocular diseaseUNIV JOHNS HOPKINS MED·Filed 2006·Application pending·0 cites
- 3355US2020277364A1TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF FabREGENXBIO INC·Filed 2018·Application pending·0 cites
- 3455US2023081539A1Suprachoroidal delivery of drug particles to reduce toxicityUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 3555US2025186252A1Method and system for delivery of therapeutics to eyeUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 3654US11268964B2Biomarkers useful in the treatment of subjects having diseases of the eyeUNIV JOHNS HOPKINS·Filed 2015·Granted Mar 8, 2022·0 cites·6 claims
- 3754US2012108654A1Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosaCAMPOCHIARO PETER A·Filed 2009·Application pending·0 cites
- 3851US2005209237A1Method for decreasing capillary permeability in the retinaBRAZZELL ROMULUS K·Filed 2003·Application pending·0 cites
- 3950US2004102444A1Method for delivering drugs to the retinaFiled 2003·Application pending·0 cites
- 4049US6214819B1Method for treating ocular neovascular diseasesNOVARTIS AG·Filed 1999·Granted Apr 10, 2001·12 cites·18 claims
- 4149US2003236246A1Method for decreasing capillary permeability in the retinaFiled 2003·Application pending·0 cites
- 4249US2015328337A1Protection from oxidative damage by gene transfer by glutamate cysteine ligase and glutathione synthaseUNIV JOHNS HOPKINS·Filed 2013·Application pending·0 cites
- 4348US2004116409A1Ocular therapyCAMPOCHIARO PETER A·Filed 2003·Application pending·0 cites
- 4448US2003040463A1TIE-2 ligands, methods of making and uses thereofFiled 2002·Application pending·0 cites
- 4545US2020179285A1Biodegradable microparticles for sustained delivery of anti-angiogenic peptideUNIV JOHNS HOPKINS·Filed 2018·Application pending·0 cites
- 4644US2019151271A1Compositions and methods for treatment of eye diseasesUNIV JOHNS HOPKINS·Filed 2018·Application pending·0 cites
- 4744US2002183253A1Method of treating ocular neovascularizationFiled 2002·Application pending·0 cites
- 4843US2016102308A1Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosaUNIV JOHNS HOPKINS·Filed 2015·Application pending·0 cites
- 4943US2007025957A1Vascular targeting of ocular neovascularizationROSENBLUM MICHAEL G·Filed 2006·Application pending·0 cites
- 5042US2006251621A1Ocular gene therapyCAMPOCHIARO PETER A·Filed 2003·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →